Skip to main content

Want a detailed portfolio tracker?

CorMedix (CRMD) P/E (2011 - 2026)

CorMedix (CRMD) P/E from Mar 31, 2011 to Jun 2, 2026. The TTM CorMedix (CRMD) P/E is 3.52. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of CorMedix (CRMD)

YearP/EChange
20263.52-35.43%
20255.45-124.12%
2024-22.60+412.83%
2023-4.41-23.00%
2022-5.72-6.79%
2021-6.14-38.05%
2020-9.91-10.39%
2019-11.06+165.11%
2018-4.17+396.68%
2017-0.84-68.22%
2016-2.64-27.25%
2015-3.63+75.88%
2014-2.07-22.10%
2013-2.65+55.62%
2012-1.70+273.55%
2011-0.46N/A

Comparison CorMedix (CRMD) P/E with competitors

CorMedix (CRMD) P/E is 3.52.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.95%
NBYStablecoin Development Corp0.10-97.10%
ENLVEnlivex Therapeutics Ltd0.15-95.73%
FGENFibroGen Inc0.24-93.18%
TRAWTraws Pharma Inc0.47-86.57%
FBIOFortress Biotech Inc0.71-79.95%
CHRSCoherus Biosciences Inc0.98-72.22%
ORMPOramed Pharmaceuticals Inc1.47-58.15%
AGENAgenus Inc2.05-41.82%
VIVSVivoSim Labs Inc2.54-27.98%
INVAInnoviva Inc3.19-9.44%
ABEOAbeona Therapeutics Inc4.20+19.44%
VXRTVaxart Inc4.26+21.04%
CVACCureVac N.V.4.45+26.27%
SRPTSarepta Therapeutics Inc4.62+31.34%
GLPGGalapagos NV4.86+38.01%
RIGLRigel Pharmaceuticals4.92+39.73%
ZVRAZevra Therapeutics Inc4.97+41.28%
ABUSArbutus Biopharma Corp5.69+61.72%
CGENCompugen Ltd7.38+109.73%
AUPHAurinia Pharmaceuticals Inc9.25+162.77%
ACADAcadia Pharmaceuticals Inc9.59+172.33%
OMEROmeros Corporation9.88+180.72%
PLXProtalix BioTherapeutics Inc9.91+181.45%
SPROSpero Therapeutics Inc10.73+204.90%
ADMAAdma Biologics Inc11.33+221.83%
SVASinovac Biotech Ltd11.44+224.82%
TBPHTheravance Biopharma Inc11.78+234.50%
HRMYHarmony Biosciences Holdings Inc12.18+245.97%
TGTXTG Therapeutics Inc13.18+274.34%
INCYIncyte Corp13.38+280.10%
SABSSAB Biotherapeutics Inc14.06+299.29%
XOMAXOMA Corp14.95+324.50%
REGNRegeneron Pharmaceuticals Inc14.98+325.49%
PBYIPuma Biotechnology Inc15.05+327.49%
EXELExelixis Inc15.79+348.63%
NAGENiagen Bioscience Inc16.35+364.54%
CPRXCatalyst Pharmaceuticals Inc17.34+392.65%
MDXGMimedx Group Inc17.38+393.52%
ARGXArgen X SE23.07+555.32%
HALOHalozyme Therapeutics Inc23.20+558.98%
XOMAOXOMA Corp25.34+619.89%
VRTXVertex Pharmaceuticals Inc25.66+628.72%
XOMAPXOMA Corp25.67+629.13%
CTMXCytomX Therapeutics Inc25.70+629.92%
ASNDAscendis Pharma A/S26.35+648.55%
RPRXRoyalty Pharma plc - Class A27.50+680.97%
SLNOSoleno Therapeutics Inc29.02+724.14%
LGNDLigand Pharmaceuticals Inc - Class B30.19+757.41%
BMRNBiomarin Pharmaceutical Inc37.51+965.35%
APLSApellis Pharmaceuticals Inc39.02+1008.35%
KRYSKrystal Biotech Inc39.70+1027.56%
GMABGenmab40.20+1041.93%
ONCBeiGene Ltd67.03+1803.81%
TECHBio-Techne Corp68.59+1848.35%
VCELVericel Corp80.63+2190.17%
PHARPharming Group N.V.87.74+2392.15%
ALNYAlnylam Pharmaceuticals Inc124.93+3448.58%
TLXTelix Pharmaceuticals Ltd139.89+3873.42%
CORTCorcept Therapeutics Inc158.39+4398.85%